Transcripts Bristol-Myers Squibb Company Buenos Aires S.E.

Acciones

BMY

ARDEUT112877

Precio de cierre Buenos Aires S.E. Otros sitios de cotización 00:00:00 19/06/2024			Varia. Cinco días.	Varia. 1 de enero.
17.573 ^ARS	+2,06 %		-0,07 %	+6,78 %

21:14	La terapia contra el cáncer colorrectal de Bristol-Myers Squibb recibe la aprobación de la FDA	MT
19:27	La FDA estadounidense aprueba la terapia contra el cáncer colorrectal de Bristol Myers	RE

Transcripts

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 11:20 AM	11/06
Transcript : Bristol-Myers Squibb Company Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	15/05
Transcript : Bristol-Myers Squibb Company Presents at Guggenheim Securities Radiopharmaceuticals Day, May-13-2024 11:00 AM	13/05
Transcript : Bristol-Myers Squibb Company, Q1 2024 Earnings Call, Apr 25, 2024	25/04
Transcript : Bristol-Myers Squibb Company Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08:30 AM	14/03
Transcript : Bristol-Myers Squibb Company Presents at Leerink Partners Global Biopharma Conference 2024, Mar-13-2024 10:00 AM	13/03
Transcript : Bristol-Myers Squibb Company Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 09:50 AM	04/03
Transcript : Bristol-Myers Squibb Company, Q4 2023 Earnings Call, Feb 02, 2024	02/02
Transcript : Bristol-Myers Squibb Company Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07:30 AM	08/01
Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs Healthcare C-Suite Unscripted Conference, Jan-04-2024 11:00 AM	04/01
Transcript : Bristol-Myers Squibb Company, Karuna Therapeutics, Inc. - M&A Call	22/12
Transcript : Bristol-Myers Squibb Company Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-16-2023 09:30 AM	16/11
Transcript : Bristol-Myers Squibb Company Presents at UBS Biopharma Conference 2023, Nov-08-2023 08:00 AM	08/11
Transcript : Bristol-Myers Squibb Company, Q3 2023 Earnings Call, Oct 26, 2023	26/10/23
Transcript : Bristol-Myers Squibb Company - Special Call	14/09/23
Transcript : Bristol-Myers Squibb Company Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 08:00 AM	11/09/23
Transcript : Bristol-Myers Squibb Company, Q2 2023 Earnings Call, Jul 27, 2023	27/07/23
Transcript : Bristol-Myers Squibb Company Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 08:40 AM	13/06/23
Transcript : Bristol-Myers Squibb Company Presents at Jefferies 2023 Global Healthcare Conference, Jun-08-2023 09:00 AM	08/06/23
Transcript : Bristol-Myers Squibb Company Presents at 2023 American Society of Clinical Oncology Annual Meeting, Jun-02-2023 through Jun-06-2023	02/06/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Titulares

Christopher Boerner, CEO de Bristol-Myers: la cartera de 16 tratamientos, la neurociencia y la oncología en el punto de mira

09 de enero 2024 a las 19:06